Patent Cliffs and Digital Integration: Analyzing the Foremost Apixaban market trends for the Next Decade
The Apixaban market is currently defined by a confluence of powerful, yet often contradictory, trends. On one hand, the clinical efficacy and ease of use of the drug continue to drive patient conversion from older therapies, securing its position as a leading oral anticoagulant. On the other, the specter of patent expiration looms large, promising to fundamentally alter the market's commercial...
0 Comments 0 Shares 119 Views 0 Reviews